(E)-3-(2-氯苯基)丙烯酰氯 | 120681-06-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 中文名称: (E)-3-(2-氯苯基)丙烯酰氯
• 中文别名: 2-丙烯酰氯化,3-(2-氯苯基)-,(E)-
• 英文名称: (E)-3-(2-chlorophenyl)acryloyl chloride
• 英文别名: 2-chlorocinnamoyl chloride；o-chloro-cinnamoyl chloride；(E)-3-(2-chlorophenyl)prop-2-enoyl chloride
• CAS: 120681-06-3
• 化学式: C₉H₆Cl₂O
• 分子量: 201.052
• InChiKey: ZAUFNZFFWDQKPL-AATRIKPKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (E)-3-(2-氯苯基)丙烯酰氯 在 吡啶 作用下， 反应 44.75h， 生成 (E)-1-(3-(2-chlorophenyl)acryloyl)-6-iodo-1H-benzo[d][1,3]oxazine-2,4-dione
  参考文献：
  名称：

  Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides

  摘要：

  Several new 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides 12a-s and 17t-v were synthesized by stirring in pyridine the (E)-3-(2-R1-3-R2-4-R3-phenyl)acrylic acid chlorides 11c-k and 11t-v with the appropriate anthranilamide derivatives 10a-c or the 5-iodoanthranilic acid 13. Some of the synthesized compounds were evaluated for their in vitro antiproliferative activity against the full NCI tumor cell line panel derived from nine clinically isolated cancer types (leukemia, non-small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast). COMPARE analysis, effects on tubulin polymerization in cells and with purified tubulin, and effects on cell cycle distribution for 17t, the most active of the series, indicate that these new antiproliferative compounds act as antitubulin agents. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.03.067
• 作为产物：
  描述：

  邻氯肉桂酸 在 氯化亚砜 作用下， 反应 5.0h， 生成 (E)-3-(2-氯苯基)丙烯酰氯
  参考文献：
  名称：

  Synthesis, antiproliferative activity, and mechanism of action of a series of 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides

  摘要：

  Several new 2-{[(2E)-3-phenylprop-2-enoyl]amino}benzamides 12a-s and 17t-v were synthesized by stirring in pyridine the (E)-3-(2-R1-3-R2-4-R3-phenyl)acrylic acid chlorides 11c-k and 11t-v with the appropriate anthranilamide derivatives 10a-c or the 5-iodoanthranilic acid 13. Some of the synthesized compounds were evaluated for their in vitro antiproliferative activity against the full NCI tumor cell line panel derived from nine clinically isolated cancer types (leukemia, non-small cell lung, colon, CNS, melanoma, ovarian, renal, prostate and breast). COMPARE analysis, effects on tubulin polymerization in cells and with purified tubulin, and effects on cell cycle distribution for 17t, the most active of the series, indicate that these new antiproliferative compounds act as antitubulin agents. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.03.067

文献信息

• 一种含肉桂酰基的一枝蒿酮酸甲酯衍生物及其制备方法和用途
  申请人：中国科学院新疆理化技术研究所

  公开号：CN112876365B

  公开（公告）日：2023-09-29

  本发明涉及一种含肉桂酰基的一枝蒿酮酸甲酯衍生物及其制备方法和用途，该类衍生物是由一枝蒿酮酸和硫酸二甲酯反应得到一枝蒿酮酸甲酯，然后在樟脑磺酰吖啶的氧化下获得2‑羟基一枝蒿酮酸甲酯，然后和肉桂酰氯在DMAP的催化下反应得到20个含肉桂酰基的一枝蒿酮酸甲酯衍生物，该方法反应条件温和，实验步骤简捷。将所得到的1d‑20d个含肉桂酰基的一枝蒿酮酸甲酯衍生物进行了初步的体外抗甲型H3N2流感病毒活性测试。实验结果表明：化合物7d,15d,18d表现出了较好的活性，可作为抗甲型H3N2流感病毒药物中的用途。
• Synthesis, Characterization, and Molecular Docking Studies of N-Acylated Butyro and Valerolactam Derivatives with Antiproliferative and Cytotoxic Activities
  作者：Mark Tristan J. Quimque、Mark John P. Mandigma、Justin Allen K. Lim、Simon Budde、Hans-Martin Dahse、Oliver B. Villaflores、Arnold V. Hallare、Allan Patrick G. Macabeo

  DOI：10.2174/1570180816666190716141524

  日期：2020.6.29

  cinnamoyl (8) butyrolactams, and, the crotonylated (10), trifluoromethylated (13), and chlorinated (14) cinnamoyl valerolactam derivatives as the most antiproliferative against human myeloid leukemia cells. The trifluoromethylated cinnamoyl valerolactam (13) displayed the best selectivity on K-562 cells. Molecular docking studies of 13 against tyrosine kinase provided evidence as tyrosine kinase inhibitor

  背景：带有迈克尔受体的亲电子化合物在抗癌药物发现中具有广阔的前景。 方法：从具有细胞毒性的Piper内酰胺生物碱中提取灵感，制备了12种N-酰化的丁酰和戊内酰胺，并评估了它们对正常人脐静脉内皮细胞（HUVEC），慢性人髓样白血病细胞（K-562）的抗增殖和细胞毒性活性，和Henrietta Lacks（HeLa）细胞用作模型细胞系。针对酪氨酸激酶进行生物活性衍生物的分子对接。 结果：MTT分析的结果表明，巴豆酰化（5）和含硝基的肉桂酰（8）丁内酰胺，以及巴豆酰化（10），三氟甲基化（13）和氯化（14）的肉桂酰戊内酰胺衍生物对人的抗增殖性最强髓样白血病细胞。三氟甲基化肉桂酰基戊内酰胺（13）在K-562细胞上显示出最佳选择性。13对酪氨酸激酶的分子对接研究提供了酪氨酸激酶抑制剂的证据，具有与伊马替尼相当的结合能和受体相互作用。 结论：亲电性N-丙烯酸部分的存在有助于该化合物作为开发抗白血病药物的灵感的潜力。
• A palladium catalyzed atom-efficient cross-coupling reactivity of triarylbismuths with α,β-unsaturated acyl chlorides
  作者：Maddali L.N. Rao、Varadhachari Venkatesh、Deepak N. Jadhav

  DOI：10.1016/j.jorganchem.2008.05.012

  日期：2008.7

  An atom-efficient cross-coupling reactivity of triarylbismuths (1 equiv) was demonstrated by cross-coupling reaction with 3 equiv of α,β-unsaturated acyl chlorides under palladium catalysis in the synthesis of a series of functionalized α, β-unsaturated ketones in high isolated yields.

  在钯催化下合成一系列官能化的α，β-不饱和酮时，通过与3当量的α，β-不饱和酰氯的交叉偶联反应，证明了三芳基铋（1当量）的原子效率的交叉偶联反应。高单产。
• Novel lapachone compounds and methods of use thereof
  申请人：Ashwell Mark A.

  公开号：US20090105166A1

  公开（公告）日：2009-04-23

  The present invention provides novel tricyclic spiro-oxathiine naphthoquinone derivatives, a synthetic method for making the derivatives, and the use of the derivatives to induce cell death and/or to inhibit proliferation of cancer or precancerous cells. The naphthoquinone derivatives of the present invention are related to the compound known as β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione).

  本发明提供了一种新型的三环螺-氧杂硫杂萘醌衍生物，一种制造该衍生物的方法，以及利用该衍生物诱导细胞死亡和/或抑制癌症或前癌细胞增殖的应用。本发明的萘醌衍生物与被称为β-拉帕醇（3,4-二氢-2,2-二甲基-2H-萘(1,2-b)吡喃-5,6-二酮）的化合物有关。
• Flash vacuum pyrolysis of stabilised phosphorus ylides. Part 6. Pyrolysis of substituted cinnamoyl ylides as a route to conjugated enynes
  作者：R. Alan Aitken、Christine Boeters、John J. Morrison

  DOI：10.1039/p19940002473

  日期：——

  The substituted cinnamoyl ylides 6 and 7, readily prepared in one step from the quaternary phosphonium salts 8 and cinnamoyl chlorides 9, undergo extrusion of Ph3PO upon FVP to give the 1,3-enynes 12 and 13 in moderate yield. At 500 °C there is little double bond isomerisation, but at 700 °C this does occur to give almost 1:1 mixtures of E and Z isomers. In a few cases, including those with a nitrophenyl

  由季phospho盐8和肉桂酰氯9一步制备的取代肉桂酸酯基化物6和7在FVP上经过Ph 3 PO挤出，以中等收率得到1,3-烯炔12和13。在500°C下几乎没有双键异构化，但是在700°C时确实发生了几乎1：1的E和Z混合物异构体。在少数情况下，包括存在硝基苯基的情况，收率很低或反应完全失败。通过使用酯稳定的内酯来改善1-苯基丁烯的不良产率的尝试仅部分成功，因为失去酯基所需的苛刻条件导致明显的异构化为萘。报告了20个炔的完全归属的13 C NMR光谱。已经制备了一个异构体β，γ-不饱和-δ-氧代酰化物的例子，14，发现在700°C下FVP上的Ph 3 P损失，从而以低收率得到了茚和苯。